Population‐attributable risk of modifiable lifestyle factors to hepatocellular carcinoma: The multi‐ethnic cohort
Alimentary Pharmacology & Therapeutics · 2023-07 · 58 (1) · 89-98
DOI: 10.1111/apt.17523 ↗At a glance
Journal article in Alimentary Pharmacology & Therapeutics, published online on 2023-04-13. Written by Kali Zhou and 5 co-authors. Institution: Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms. Cited 16 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIEHS NIH HHS, NCI NIH HHS, NIDDK NIH HHS.
Abstract (original language)
Background and Aims Lifestyle factors are well associated with risk of hepatocellular carcinoma (HCC). However, the impact of reducing adverse lifestyle behaviours on population‐level burden of HCC is uncertain.
Methods
We conducted prospective analysis of the population‐based multi‐ethnic cohort (MEC) with linkage to cancer registries. The association of lifestyle factors (smoking, alcohol, diet quality assessed by alternate Mediterranean diet score, coffee drinking, physical activity and body mass index) with HCC incidence was examined using Cox regression. Population‐attributable risk (PAR, %) for the overall, lean and overweight/obese populations was determined.
Results
A total of 753 incident cases of HCC were identified in 181,346 participants over median follow‐up of 23.1 years. Lifestyle factors associated with elevated HCC risk included former/current smoking, heavy alcohol use, poor diet quality, lower coffee intake and obesity, but not physical activity. The lifestyle factor with highest PAR was lower coffee intake (21.3%; 95% CI: 8.9%–33.0%), followed by current smoking (15.1%; 11.1%–19.0%), obesity (14.5%; 9.2%–19.8%), heavy alcohol use (7.1%; 3.5%–10.6%) and lower diet quality (4.1%; 0.1%–8.1%). The combined PAR of all high‐risk lifestyle factors was 51.9% (95% CI: 30.1%–68.6%). A higher combined PAR was observed among lean (65.2%, 26.8%–85.7%) compared to overweight/obese (37.4%, 11.7%–58.3%) participants. Adjusting for viral hepatitis status in a linked MEC‐Medicare dataset resulted in similar PAR results.
Conclusions
Modifying lifestyle factors, particularly coffee intake, may have a substantial impact on HCC burden in diverse populations, with greater impact among lean adults. Diet and lifestyle counselling should be incorporated into HCC prevention strategies.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- Research Center for Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
ORCID profiles: Kali Zhou
Funding
- NIEHS NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
- National Cancer Institute
Cite
APA
Zhou, K., Lim, T., Dodge, J. L., Terrault, N. A., Wilkens, L. R., & Setiawan, V. W. (2023). Population‐attributable risk of modifiable lifestyle factors to hepatocellular carcinoma: The multi‐ethnic cohort. Alimentary Pharmacology & Therapeutics, 58(1), 89-98. https://doi.org/10.1111/apt.17523
Vancouver
Zhou K, Lim T, Dodge JL, Terrault NA, Wilkens LR, Setiawan VW. Population‐attributable risk of modifiable lifestyle factors to hepatocellular carcinoma: The multi‐ethnic cohort. Alimentary Pharmacology & Therapeutics. 2023;58(1):89-98. doi:10.1111/apt.17523
BibTeX
@article{Zhou2023,
author = {Zhou, Kali and Lim, Tiffany and Dodge, Jennifer L and Terrault, Norah A and Wilkens, Lynne R and Setiawan, V Wendy},
title = {Population‐attributable risk of modifiable lifestyle factors to hepatocellular carcinoma: The multi‐ethnic cohort},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
volume = {58},
number = {1},
pages = {89--98},
doi = {10.1111/apt.17523}
}
EUVIMED